| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |